Showing results (261-270 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|November 21, 2008
VKORC1 and CYP2C9 allelic variants influence acenocoumarol dose requirements in Greek patientsChristos N Markatos, Elissavet Grouzi, Marianna Politou, et al.
Pharmacogenomics|August 25, 2007
miRNAs: from neurogeneration to neurodegenerationSunit Kumar Singh
Pharmacogenomics|August 25, 2007
Protein kinases as targets for cancer treatmentGeorgios Giamas, Justin Stebbing, Constantinos E Vorgias, et al.
Pharmacogenomics|August 25, 2007
SimuGen Ltd: reliable, early prediction of drug toxicity with toxicogenomics, human cell culture and computational modelsQuin Wills
Pharmacogenomics|November 25, 2016
Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancerTristan M Sissung, John Deeken, Crystal R Leibrand, et al.
Pharmacogenomics|November 26, 2016
Effect of an SNP in SCAP gene on lipid-lowering response to rosuvastatin in Indian patients with metabolic syndromeMisbahuddin M Rafeeq, Farida Ahmad, Syed Z Rahman, et al.
Pharmacogenomics|November 26, 2016
INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapineSuvi Koskinen, Olli Kampman, Anssi Solismaa, et al.
Pharmacogenomics|March 26, 2021
Integrating disease and drug-related phenotypes for improved identification of pharmacogenomic variantsTom W Ouellette, Galen Eb Wright, Britt I Drögemöller, et al.
Pharmacogenomics|August 5, 2020
PARC report: a health-systems focus on reimbursement and patient access to pharmacogenomics testingSara L Rogers, Nicholas J Keeling, Jyothsna Giri, et al.
Pharmacogenomics|July 9, 2020
PARC report: a perspective on the state of clinical pharmacogenomics testingJennifer Eichmeyer, Sara Rogers, Christine M Formea, et al.
Pageof 274